GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Defining the role of innate immune cells in the early stages of immune surveillance of skin cancer by using a novel model that allows in vivo imaging of the immunoediting process.

$457,791
Dennis Roop · University Of Colorado Denver · R01 · FY2025 · AR

Targeting PP4 to improve ovarian cancer response to immunotherapy

$457,776
Marion Curtis · Mayo Clinic Arizona · R37 · FY2025 · CA

Neoadjuvant Immunotherapy with Intratumoral CPG and PD-1 Blockade in Melanoma

$457,754
Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA

Modulating Intratumoral Immune Composition to Enhance Immunotherapy

$457,683
Edwin Manuel · Beckman Research Institute/City Of Hope · R21 · FY2024 · CA

An Environmental Chemical Receptor, the AhR, as a Mediator of Multiple Immune Checkpoints in Oral Cancer

$457,675
David H Sherr · Boston University Medical Campus · R01 · FY2024 · ES

Targeting Stromal Influences on Glutamine Addiction in Ovarian Cancer

$457,671
Deepak Nagrath · University Of Michigan At Ann Arbor · R01 · FY2019 · CA

Defining the Role of Tumor-Neural Crosstalk in head and Neck Cancer Progression and Treatment Resistance

$457,663
Moran Amit · University Of Tx Md Anderson Can Ctr · R37 · FY2022 · CA

Defining the Role of Tumor-Neural Crosstalk in head and Neck Cancer Progression and Treatment Resistance

$457,663
Moran Amit · University Of Tx Md Anderson Can Ctr · R37 · FY2020 · CA

Defining the Role of Tumor-Neural Crosstalk in head and Neck Cancer Progression and Treatment Resistance

$457,663
Moran Amit · University Of Tx Md Anderson Can Ctr · R37 · FY2021 · CA

LILRB modulates tumor microenvironment and promotes tumor progression

$457,636
Shu-Hsia Chen · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · CA

Aak1 to increase infiltration of adoptively transferred cells into solid tumors

$457,635
Laura Marie Rogers · Mayo Clinic Rochester · R37 · FY2025 · CA

Aak1 to increase infiltration of adoptively transferred cells into solid tumors

$457,635
Laura Marie Rogers · Mayo Clinic Rochester · R37 · FY2023 · CA

Kinase Signaling in Epidermal Homeostasis and Early Neoplasia

$457,633
Carolyn S. Lee · University Of Virginia · R01 · FY2025 · CA

Defining the impact of stromal aging on ovarian cancer initiation

$457,624
Lan Coffman · University Of Pittsburgh At Pittsburgh · U01 · FY2022 · AG

Penn Small Animal Imaging Resource (Penn-SAIR)

$457,562
Jerry D Glickson · University Of Pennsylvania · U24 · FY2008 · CA

Non-invasive Quantification of Dose-Exposure-Response of PD-L1 Therapeutics at the Tumor

$457,540
Sridhar Nimmagadda · Johns Hopkins University · R01 · FY2020 · CA

Non-invasive Quantification of Dose-Exposure-Response of PD-L1 Therapeutics at the Tumor

$457,540
Sridhar Nimmagadda · Johns Hopkins University · R01 · FY2021 · CA

Therapeutic targeting of CD206+ TAMs to enhance adaptive and innate anti-tumor immune responses in metastatic castration-resistant prostate cancer

$457,524
Jelani Chinelo Zarif · Johns Hopkins University · R01 · FY2023 · CA

Posttranslational regulation of macropinocytosis in pancreatic cancer

$457,503
Brittany Allen-Petersen · Purdue University · R01 · FY2025 · CA

Clinical and Laboratory Research Training for Surgical Oncologists

$457,466
Lei Zheng · Johns Hopkins University · T32 · FY2021 · CA

Clinical implementation of single cell tumor transcriptome analysis

$457,465
Aviv Regev · Broad Institute, Inc. · R33 · FY2016 · CA

The Role of Proteases and Peptides in Cancer Pain

$457,397
Brian L Schmidt · New York University · R01 · FY2010 · DE

Project 2: Near-Infrared Targeted Tracers for Intraoperative Identification of NSCLC

$457,389
Philip Stewart Low · University Of Pennsylvania · P01 · FY2022 · CA

Hepatic steatosis promotes liver metastasis

$457,219
Steven L Teitelbaum · Washington University · R01 · FY2022 · CA

Detection of in vivo enzyme activities with CEST MRI

$457,211
Mark David Pagel · University Of Arizona · R01 · FY2015 · CA